# Unlocking Cannabis-Derived Mosquito Repellents: Camphor’s Role Explained > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-derived-mosquito-repellents-camphor-protection/ > **Published:** 2026-04-25T04:51:13-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:58:22-04:00 > **Clinical Summary:** Explore cannabis-derived mosquito repellents and how camphor in essential oils offers natural insect protection with potential clinical relevance. --- ✦ New CED Clinical Relevance #2 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. ResearchSafetyHemp Clinical Summary Researchers have identified the mechanism by which camphor, a compound present in cannabis essential oils, repels mosquitoes, providing insight into the plant’s natural insecticidal properties. This mechanistic understanding of cannabis-derived compounds could inform the development of topical formulations for patients seeking natural alternatives to conventional insect repellents, particularly those with sensitivities to synthetic DEET-based products. While this finding is primarily relevant to the pharmacology of cannabis constituents rather than direct therapeutic applications, it expands the clinical utility profile of cannabis-derived products beyond traditional indications. The identification of camphor’s mode of action may support the development of cannabis-based topical preparations with dual purposes: [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/) and practical mosquito repellency for patients in endemic regions. Clinicians should remain aware that cannabis-derived insect repellent products are not currently standardized or regulated as pharmaceuticals in most jurisdictions, so patients using such formulations should be counseled on the lack of clinical safety and efficacy data compared to established repellents. For now, this research has primarily academic and product development relevance rather than direct clinical implications for prescribing cannabis therapeutically. Dr. Caplan’s Take “What we’re learning about cannabis terpene profiles, including camphor, has real clinical applications beyond psychoactivity, and this kind of basic research helps us understand why patients report specific symptom relief with certain cultivars rather than others, which ultimately improves our ability to make evidence-based recommendations.” Clinical Perspective While this study on cannabis-derived compounds and mosquito repellency is scientifically interesting, clinicians should recognize that the leap from laboratory findings about essential oil components to human clinical efficacy and safety remains substantial and unvalidated. The identification of camphor and related terpenes as mosquito repellents does not establish their effectiveness as topical agents for disease vector prevention in real-world conditions, nor does it address potential dermatologic effects, systemic absorption, or [drug interactions](https://cedclinic.com/cannabis-liver-interactions-study-insights/) in clinical populations. Given the current lack of controlled human trials, cannabis-based repellent products should not yet be recommended as a substitute for evidence-based approaches like DEET or picaridin for patients seeking protection against mosquito-borne illness. Clinicians should counsel patients skeptical of conventional repellents that enthusiasm for botanical alternatives must be balanced against the established safety and efficacy data, while remaining open to future research that may clarify whether cannabis 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20%3Cb%3ECannabis%3C%2Fb%3E%20essential%20oils%20unlock%20how%20camphor%20repels%20mosquitoes%20%E2%80%93%20Phys.org%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-essential-oils-unlock-how-camphor-repels-mosquitoes-phys-org%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-essential-oils-unlock-how-camphor-repels-mosquitoes-phys-org%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20%3Cb%3ECannabis%3C%2Fb%3E%20essential%20oils%20unlock%20how%20camphor%20repels%20mosquitoes%20%E2%80%93%20Phys.org%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fcannabis-essential-oils-unlock-how-camphor-repels-mosquitoes-phys-org%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Strawberry Cough Strain: History, Effects, Terpenes, and Everything Yo](https://cedclinic.com/strawberry-cough-strain-history-effects-terpenes-and-everything-yo/) Discover the unique terpene profile and effects of the Strawberry Cough cannabis strain, including its therapeutic potential and user experience. [Learn More](https://cedclinic.com/strawberry-cough-strain-history-effects-terpenes-and-everything-yo/) [How U.S. marijuana reclassification could help cannabis companies – The Detroit News](https://cedclinic.com/marijuana-reclassification-impact-cannabis-companies/) Explore the impact of marijuana reclassification on the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) and potential benefits for companies navigating regulatory changes. [Read Article](https://cedclinic.com/marijuana-reclassification-impact-cannabis-companies/) [Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by …](https://cedclinic.com/cannabis-pharmaceuticals-business-research-report-2026-an-111-1-billion-market-by/) Gain insights into the booming cannabis pharmaceuticals market projected to reach $111.1 billion by 2026, highlighting growth drivers and trends. [Explore Report](https://cedclinic.com/cannabis-pharmaceuticals-business-research-report-2026-an-111-1-billion-market-by/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).